Memorial Sloan-Kettering Cancer Center Commack: Clinical Trials at Commack

Browse our continually updated listing of clinical trials available to patients at Memorial Sloan-Kettering Cancer Center Commack below. You can also explore our complete listing of clinical trials available at Memorial Sloan-Kettering.

Showing 1 - 20 of 98 trials
Titlesort icon Investigator Disease(s)
A Comprehensive Assessment to Predict Side Effects from Chemotherapy and an Evaluation of Pre-Phase Chemotherapy in Older Patients with Non-Hodgkin Lymphoma
[Protocol 13-028] 		Hamlin, Paul
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Genotype-Phenotype Urothelial Cancer Study
[Protocol 09-025] 		Bajorin, Dean
  • Bladder Cancer
  • Hereditary Cancer & Genetics
A Long-Term Study of Sexual and Reproductive Health in Women with Breast Cancer and Lymphoma
[Protocol 12-249] 		Goldfarb, Shari
  • Breast Cancer
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
  • Survivorship
A Phase I Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer
[Protocol 09-035] 		Zelefsky, Michael
  • Prostate Cancer
    • Localized Disease
A Phase I Dose-Escalation Study of Image-Guided Radiation Therapy for Bladder Cancer Patients Undergoing Radiotherapy and Concurrent Gemcitabine Chemotherapy
[Protocol 10-031] 		Kollmeier, Marisa
  • Bladder Cancer
A Phase I Study of Afatinib with Chemotherapy and Radiation Therapy in Patients with EGFR-Mutant Non-Small Cell Lung Cancer
[Protocol 12-279] 		Chaft, Jamie
  • Lung Cancer, Non-Small Cell
A Phase I Study of Hypofractionated Stereotactic Radiosurgery with Bevacizumab to Treat Recurrent Malignant Glioma
[Protocol 11-057] 		Omuro, Antonio
  • Brain Tumors, Primary
  • Pediatric Brain Tumors
    • Brain Cancer
A Phase I Study of LDE225 with Etoposide and Cisplatin for the Initial Treatment of Extensive Small Cell Lung Cancer
[Protocol 11-206] 		Pietanza, M. Catherine
  • Lung Cancer
  • Lung Cancer, Small Cell
    • Other
A Phase I Study of Stereotactic Body Radiation Therapy for Inoperable Locally Advanced Non-Small Cell Lung Cancer
[Protocol 13-113] 		Rimner, Andreas
  • Lung Cancer, Non-Small Cell
A Phase I Study of TRC105 plus Bevacizumab in Patients with Recurrent Glioma
[Protocol 12-217] 		Omuro, Antonio
  • Brain Tumors, Primary
    • Gliomas
A Phase I-II Study of Dasatinib plus Paclitaxel in Patients with Metastatic Breast Cancer
[Protocol 08-122] 		Fornier, Monica
  • Breast Cancer
A Phase I/II Clinical Trial of Temsirolimus plus Neratinib for Patients with Metastatic HER2-Amplified or Triple-Negative Breast Cancer
[Protocol 10-005] 		Chandarlapaty, Sarat
  • Breast Cancer
A Phase I/II Study of Cabozantinib (XL184) in Patients with Recurrent or Persistent Myeloma
[Protocol 12-240] 		Giralt, Sergio
  • Hematology
    • Multiple Myeloma
A Phase I/II Study of Crizotinib and STA-9090 in ALK-Positive Lung Cancers
[Protocol 12-015] 		Riely, Gregory
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase I/II Study of Intrathecal Trastuzumab in Women with HER2-Positive Breast Cancer that Spread to the Spinal Fluid
[Protocol 12-123] 		Pentsova, Elena
  • Breast Cancer
A Phase I/II Study of Sequential Chemoradiation Followed by Autologous Stem Cell Transplant in Patients with Untreated Advanced Mantle Cell Lymphoma
[Protocol 11-095] 		Zelenetz, Andrew
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study Comparing Three Months versus Two Years of Afatinib Therapy after Surgery for Patients with Stage I-III Non-Small Cell Lung Cancer
[Protocol 13-096] 		Chaft, Jamie
  • Lung Cancer, Non-Small Cell
A Phase II Study Evaluating Manuka Honey to Reduce Chemoradiation-Associated Esophagitis Pain during Lung Cancer Treatment
[Protocol 12-111] 		Rimner, Andreas
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
  • Lung Cancer, Small Cell
    • Other
A Phase II Study of Bortezomib in Patients with KRAS-Mutant Non-Small Cell Lung Cancer
[Protocol 12-222] 		Riely, Gregory
  • Lung Cancer, Non-Small Cell
A Phase II Study of Bortezomib/Dexamethasone Followed by Lenalidomide in Nonresponders as Initial Treatment for Multiple Myeloma
[Protocol 13-064] 		Hassoun, Hani
  • Hematology
    • Multiple Myeloma